Career Development Program

爱荷华州/马约诊所淋巴瘤孢子的大学的目标（UI/MC淋巴瘤孢子）职业生涯 发展计划（CDP）旨在培养知识渊博、训练有素、经验丰富的科学家， 多学科研究，为今后的研究转化淋巴瘤的研究。提供充足的 培训和职业提升的机会是爱荷华州大学和马约诊所的首要任务 科学界。这两个机构拥有广泛的研究和培训基础， 强烈支持UI/MC淋巴瘤孢子CDP. CDP的主要目标是：（1）培训 年轻的研究人员（高级博士后研究员和年轻的教师）在翻译，多学科临床或 基础淋巴瘤研究;（2）重新定向已建立的研究人员进一步淋巴瘤研究;和（3） 与其他机构的研究人员合作，他们有兴趣从事以下领域的研究工作： 转化淋巴瘤研究。在最初的资助期间，6名年轻的研究人员获得了奖励。 他们的工作导致发现了新的易位，潜在的抗原呈递新方法， 以及正在临床试验中的新疗法。在下一个资助期间，UI/MC 淋巴瘤孢子将保持：（1）严格的候选人选拔制度;（2）全面的培训生 来自两个研究中心的导师和其他研究人员的指导;（3）通过科学导师小组提供支持 (the个别培训生咨询委员会），由来自两个研究中心的研究者组成，每个研究中心都具有专业知识 （4）多学科研究课程及持续的培训活动，例如 多学科癌症研讨会系列和淋巴瘤小组会议在这两个网站;（5）鼓励 与两个研究中心的研究者小组会议合作;（6）鼓励与 研究人员在爱荷华州和马约和（7）的机会，研究增强通过 发展研究计划。

The goal of the University of Iowa/Mayo Clinic Lymphoma SPORE (UI/MC Lymphoma SPORE) Career Development Program (CDP) is to develop knowledgeable, well-trained scientists experienced in multidisciplinary research for future studies in translational lymphoma research. The provision of ample opportunities for training and career enhancement is a top priority of the University of Iowa and Mayo Clinic scientific communities. The extensive research and training base available at these two institutions provides strong support for the UI/MC Lymphoma SPORE CDP. The primary objectives of the CDP are to: (1) train young investigators (senior postdoctoral fellows and young faculty) in translational, multidisciplinary clinical or basic lymphoma research; (2) redirect established investigators to further lymphoma research; and (3) collaborate with investigators from other institutions who are interested in pursuing a research career in translational lymphoma research. During the initial funding period 6 young investigators received awards. Their work has led to the discovery of novel translocations, potential new methods of antigen presentation, and new treatments that are now being tested in clinical trials. During the next funding period, the UI/MC Lymphoma SPORE will maintain: (1) a stringent candidate selection system; (2) comprehensive trainee guidance by a mentor and other investigators from both sites; (3) support through a scientific mentor group (the Individual Trainee Advisory Committee) comprised of investigators from both sites with expertise in each trainee's area of interest; (4) multi-disciplinary research courses and on-going training activities such as the Multidisciplinary Cancer Seminar Series and Lymphoma Group meetings at both sites; (5) encouragement of collaboration with Investigator Group meetings at both sites; (6) encouragement of collaboration with investigators at both Iowa and Mayo and (7) opportunities for research enhancement through the Developmental Research Program.